Submission for OMB Review; Screening Tool for Unaccompanied Children Program Staff and Visitors, 57434-57435 [2021-22477]

Download as PDF 57434 Federal Register / Vol. 86, No. 197 / Friday, October 15, 2021 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families [OMB #0970–0198] Proposed Information Collection Activity; Child Care and Development Fund Plan for Tribes for FY 2023–2025 (ACF–118A) Office of Child Care; Administration for Children and Families; HHS. ACTION: Request for public comment. AGENCY: The Administration for Children and Families (ACF) is requesting a 3-year extension of the form ACF–118A: Child Care and Development Fund for Tribes (OMB #0970–0198, expiration 06/30/2022) for FFY 2023–2025. There are changes requested to the form to improve formatting, and clarify and streamline SUMMARY: questions. ACF is also requesting public comment on revising the thresholds used to determine tribes with small, medium, and large allocations. DATES: Comments due within 60 days of publication. In compliance with the requirements of the Paperwork Reduction Act of 1995, ACF is soliciting public comment on the specific aspects of the information collection described above. ADDRESSES: Copies of the proposed collection of information can be obtained and comments may be forwarded by emailing infocollection@ acf.hhs.gov. All requests should be identified by the title of the information collection. SUPPLEMENTARY INFORMATION: Description: The Child Care and Development Fund (CCDF) Plan (the Plan) for Tribes is required from each CCDF Lead Agency in accordance with section 658E of the Child Care and Development Block Grant Act of 1990 (CCDBG Act), as amended, CCDBG Act of 2014 (Pub. L. 113–186), and 42 U.S.C. 9858. The Plan, submitted on the ACF– 118A, is required triennially, and remains in effect for 3 years. The Plan provides ACF and the public with a description of and assurance about the tribes’ child care programs. These Plans are the applications for CCDF funds. ACF is also seeking public comment on whether and how to adjust the thresholds used to determine allocation sizes for Tribal Lead Agencies. We differentiate and exempt some Tribal Lead Agencies from a progressive series of CCDF provisions based on three categories of CCDF grant allocations— large, medium, and small. However, the current thresholds were set based on FFY 2016 allocations. Since then, the amount annually appropriated to Tribal Lead Agencies has increased more than threefold and ACF is considering adjusting the thresholds accordingly. Respondents: Tribal CCDF lead agencies. ANNUAL BURDEN ESTIMATES Instrument Total number of respondents Total number of responses per respondent 260 106 1 1 ACF–118A Part I (for all tribes) ......................................... ACF–118A Part II (for medium and large tribes only) ....... Estimated Total Annual Burden Hours: 11,248. Comments: The Department specifically requests comments on (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Authority: Pub. L. 113–186 and 42 U.S.C. 9858c. Mary B. Jones, ACF/OPRE Certifying Officer. [FR Doc. 2021–22456 Filed 10–14–21; 8:45 am] BILLING CODE 4184–43–P VerDate Sep<11>2014 16:50 Oct 14, 2021 Jkt 256001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families [0970–0543] Submission for OMB Review; Screening Tool for Unaccompanied Children Program Staff and Visitors Office of Refugee Resettlement; Administration for Children and Families, Department of Health and Human Services. ACTION: Request for public comment. AGENCY: The Office of Refugee Resettlement (ORR), Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), is proposing to continue use of a coronavirus (COVID–19) screening tool for unaccompanied children (UC) program staff and visitors at ORR care provider facilities. DATES: Comments due within 30 days of publication. The Office of Management and Budget (OMB) must make a decision about the collection of information between 30 and 60 days after publication of this document in the SUMMARY: PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 Average burden hours per response 120 24 Total burden hours 31,200 2,544 Annual burden hours 10,400 848 Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. All emailed requests should be identified by the title of the information collection. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. SUPPLEMENTARY INFORMATION: Description: The COVID–19 Verbal Screening and Temperature Check tool is verbally administered to all staff and visitors before they are granted access an ORR care provider facility. The tool asks whether the individual displays COVID–19 symptoms, has had close contact with individuals known to test positive for COVID–19, has been tested for COVID–19, has been exposed to someone known or suspected to be infected with COVID–19, or has been tested for COVID–19. The tool also requests a temperature check. The information collected by administering E:\FR\FM\15OCN1.SGM 15OCN1 Federal Register / Vol. 86, No. 197 / Friday, October 15, 2021 / Notices this screening tool will help ensure the health and safety of children and staff at care provider facilities by helping to identify and reduce potential exposure to COVID–19. 57435 Respondents: Staff and visitors at ORR care provider facilities. ANNUAL BURDEN ESTIMATES Instrument Total number of respondents Annual responses per respondent Average burden hours per response Annual burden hours COVID–19 Verbal Screening and Temperature Check .................................. 15,000 260 .033 128,700 Authority: 6 U.S.C. 279. Mary B. Jones, ACF/OPRE Certifying Officer. [FR Doc. 2021–22477 Filed 10–14–21; 8:45 am] BILLING CODE 4184–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2021–N–1004] Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act; Public Meeting; Request for Comments Food and Drug Administration, Department of Health and Human Services (HHS). ACTION: Notice of public meeting; request for comments. AGENCY: The Food and Drug Administration (FDA or the Agency) is announcing a virtual public meeting entitled ‘‘Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act (DSCSA).’’ This public meeting is intended to provide members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to discuss enhanced drug distribution security requirements of the DSCSA related to system attributes necessary to enable secure tracing of product at the package level. DATES: The public meeting will be held on November 16, 2021, from 9 a.m. to 4 p.m., and will take place virtually. Submit either electronic or written comments on this public meeting by January 18, 2022. ADDRESSES: The public meeting will be held virtually and hosted by FDA. Registration to participate in this meeting and other information can be found at https://www.fda.gov/drugs/ news-events-human-drugs/publicmeeting-enhanced-drug-distributionsecurity-package-level-under-drugsupply-chain-security. See the SUPPLEMENTARY INFORMATION section for registration date and other information. SUMMARY: VerDate Sep<11>2014 16:50 Oct 14, 2021 Jkt 256001 Comments: To permit the widest possible opportunity to obtain public comment, FDA is soliciting either electronic or written comments on all aspects of the public meeting topics. You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Please note that the deadline for submitting either electronic or written comments is 60 days after the meeting, January 18, 2022, to which the comments relate. Comments received by mail/hand delivery/courier (for written/ paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. The https:// www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of the specified date. Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2021–N–1004 for ‘‘Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act; Public Meeting; Request for Comments.’’ Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240–402–7500. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as E:\FR\FM\15OCN1.SGM 15OCN1

Agencies

[Federal Register Volume 86, Number 197 (Friday, October 15, 2021)]
[Notices]
[Pages 57434-57435]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-22477]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Children and Families

[0970-0543]


Submission for OMB Review; Screening Tool for Unaccompanied 
Children Program Staff and Visitors

AGENCY: Office of Refugee Resettlement; Administration for Children and 
Families, Department of Health and Human Services.

ACTION: Request for public comment.

-----------------------------------------------------------------------

SUMMARY: The Office of Refugee Resettlement (ORR), Administration for 
Children and Families (ACF), U.S. Department of Health and Human 
Services (HHS), is proposing to continue use of a coronavirus (COVID-
19) screening tool for unaccompanied children (UC) program staff and 
visitors at ORR care provider facilities.

DATES: Comments due within 30 days of publication. The Office of 
Management and Budget (OMB) must make a decision about the collection 
of information between 30 and 60 days after publication of this 
document in the Federal Register. Therefore, a comment is best assured 
of having its full effect if OMB receives it within 30 days of 
publication. All emailed requests should be identified by the title of 
the information collection.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.

SUPPLEMENTARY INFORMATION:
    Description: The COVID-19 Verbal Screening and Temperature Check 
tool is verbally administered to all staff and visitors before they are 
granted access an ORR care provider facility. The tool asks whether the 
individual displays COVID-19 symptoms, has had close contact with 
individuals known to test positive for COVID-19, has been tested for 
COVID-19, has been exposed to someone known or suspected to be infected 
with COVID-19, or has been tested for COVID-19. The tool also requests 
a temperature check. The information collected by administering

[[Page 57435]]

this screening tool will help ensure the health and safety of children 
and staff at care provider facilities by helping to identify and reduce 
potential exposure to COVID-19.
    Respondents: Staff and visitors at ORR care provider facilities.

                                             Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
                                                                    Annual      Average  burden
                 Instrument                   Total number of   responses per      hours  per     Annual  burden
                                                 respondents      respondent        response          hours
----------------------------------------------------------------------------------------------------------------
COVID-19 Verbal Screening and Temperature             15,000              260             .033          128,700
 Check......................................
----------------------------------------------------------------------------------------------------------------

    Authority: 6 U.S.C. 279.

Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2021-22477 Filed 10-14-21; 8:45 am]
BILLING CODE 4184-45-P